Enalare Therapeutics
Internationally recognized thought leader in areas of perioperative and pain medicines, drug development and regulatory affairs
Highly published in top tier journals
Frequent scientific advisor for public and private companies
Serial entrepreneur, started more than 20 companies
Johns Hopkins School of Medicine
Georgetown School of Medicine – residency
This person is not in any teams
This person is not in any offices
Enalare Therapeutics
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.